[1]
Nieto-Rios, J.F., Gómez de los Ríos, S.M., Serna-Higuita, L.M., Ocampo-Kohn, C., Aristizabal-Alzate, A., Gálvez-Cárdenas, K.M. and Zuluaga-Valencia, G.A. 2024. Treatment of post-transplantation lymphoproliferative disorders after kidney transplant with rituximab and conversion to m-TOR inhibitor. Colombia Medica. 47, 4 (Jun. 2024), 196–202. DOI:https://doi.org/10.25100/cm.v47i4.1989.